What is it about?
The prevalence of CKD in Nigeria is rising especially with increase in risk behaviors/factors such as low-income occupation, smoking, alcoholism, old age, obesity, hypertension, diabetes mellitus, family history of hypertension, family history of Renal disease, use of traditional medication, female gender and anemia. This study was a systematic review of the prevalence of CKD in Nigeria using kidney disease outcome quality initiative (KDOQI) practice guidelines, which uses three methods of assessing GFR (Cockcrauft, Modification of diet in renal disease, MDRD and CKD-EPI) in defining CKD.
Featured Image
Why is it important?
There is dearth of statistics on the prevalence of CKD and the best possible methods of its assessment over the years. This study has shown that out of the three methods of estimating equations for GFR, MDRD and CKD-EPI recorded more agreeable values, hence recommendable as KDOQI methods for defining CKD in Nigeria. The prevalence of CKD from this study ranged from 2.5% to 14.2% using the two recommendable methods for estimating equations for GFR.
Perspectives
This study is an advocacy on promoting the awareness of CKD and the possible risk factors in Nigeria. It also serves a protective role to the target population as it discussed the KDOQI, with recommendations on the best performing methods of diagnosis of CKD in the environment. A little use of behavioral theoretical approach on how to prevent kidney disease in the environment was highlighted, i.e. Periodic (3 monthly) screening for CKD when GFR < 60 mL/min/1.7 sq. meter and avoidance of above possible risk factors were strongly recommended during counseling.
Dr Ogbonna Collins Nwabuko
Federal Medical Center, Umuahia.
The article is quite informative about the prevalence of chronic kidney disease in Nigeria,
Dr. Innocent Ijezie Chukwuonye
Federal Medical Centre Umuahia, Abia State Nigeria
Read the Original
This page is a summary of: Prevalence of chronic kidney disease in Nigeria: systematic review of population-based studies, International Journal of Nephrology and Renovascular Disease, May 2018, Dove Medical Press,
DOI: 10.2147/ijnrd.s162230.
You can read the full text:
Contributors
The following have contributed to this page
